Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 6/20 | 0.48 |
| ▸ | GABRP | O00591 | 2/20 | 0.43 |
| ▸ | GABRD | O14764 | 2/20 | 0.43 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.43 |
| ▸ | GABRB1 | P18505 | 2/20 | 0.43 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.43 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.43 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.43 |
| ▸ | GABRA3 | P34903 | 2/20 | 0.43 |
| ▸ | GABRA2 | P47869 | 2/20 | 0.43 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.43 |
| ▸ | GABRA4 | P48169 | 2/20 | 0.43 |
| ▸ | GABRE | P78334 | 2/20 | 0.43 |
| ▸ | GABRA6 | Q16445 | 2/20 | 0.43 |
| ▸ | GABRG1 | Q8N1C3 | 2/20 | 0.43 |
| ▸ | GABRG3 | Q99928 | 2/20 | 0.43 |
| ▸ | GABRQ | Q9UN88 | 2/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.43 |
| ▸ | ANPEP | P15144 | 4/20 | 0.41 |
| ▸ | ENPEP | Q07075 | 4/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL325264 | 0.74 | CYP1A2 (0.50) | FOLH1GABRPGABRDGABRA1GABRB1 | |
| SCHEMBL27460151 | 0.73 | GABRP (0.54) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL326407 | 0.71 | FOLH1 (0.45) | FOLH1GABRPGABRDGABRA1GABRB1 | |
| SCHEMBL1131636 | 0.70 | — | — | |
| SCHEMBL29257612 | 0.70 | — | — | |
| SCHEMBL11765423 | 0.69 | FOLH1 (0.55) | FOLH1GABRPGABRDGABRA1GABRB1 | |
| SCHEMBL911280 | 0.69 | — | — | |
| Hydrochloric Acid SCHEMBL9106970 | 0.69 | — | — | |
| SCHEMBL29151536 | 0.68 | FOLH1 (0.43) | FOLH1GABRPGABRDGABRA1GABRB1 | |
| SCHEMBL27895479 | 0.68 | GABRP (0.54) | FOLH1GABRPGABRDGABRA1GABRB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2408740-B1 | COMPOUNDS FOR TREATING INFLAMMATION AND PAIN | OLATEC IND LLC (US) | 2013-11-20 | — | — | EP | disclosed |
| CN-102438983-A | Compounds for the treatment of inflammation and pain | OLATEC IND LLC | 2012-05-02 | — | — | CN | disclosed |
| CN-102438983-A | Compounds for the treatment of inflammation and pain | OLATEC IND LLC | 2012-05-02 | — | — | CN | disclosed |
| EP-2408740-A2 | COMPOUNDS FOR TREATING INFLAMMATION AND PAIN | Olatec Industries LLC (US) | 2012-01-25 | — | — | EP | disclosed |
| EP-2408740-A2 | COMPOUNDS FOR TREATING INFLAMMATION AND PAIN | Olatec Industries LLC (US) | 2012-01-25 | — | — | EP | disclosed |
| WO-2010107807-A3 | COMPOUNDS FOR TREATING INFLAMMATION AND PAIN | OLATEC INDUSTRIES LLC (US) | 2011-01-13 | — | — | WO | disclosed |
| US-7851650-B2 | Compounds for treating inflammation and pain | OLATEC INDUSTRIES LLC (US) | 2010-12-14 | — | — | US | disclosed |
| US-7851650-B2 | Compounds for treating inflammation and pain | OLATEC INDUSTRIES LLC (US) | 2010-12-14 | — | — | US | disclosed |
| US-20100240756-A1 | COMPOUNDS FOR TREATING INFLAMMATION AND PAIN | OLATEC THERAPEUTICS LLC | 2010-09-23 | — | — | US | disclosed |
| US-20100240756-A1 | COMPOUNDS FOR TREATING INFLAMMATION AND PAIN | OLATEC THERAPEUTICS LLC | 2010-09-23 | — | — | US | disclosed |
| WO-2010107807-A2 | COMPOUNDS FOR TREATING INFLAMMATION AND PAIN | OLATEC INDUSTRIES LLC (US) | 2010-09-23 | — | — | WO | disclosed |
| WO-2010107807-A2 | COMPOUNDS FOR TREATING INFLAMMATION AND PAIN | OLATEC INDUSTRIES LLC (US) | 2010-09-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100240756-A1 | COMPOUNDS FOR TREATING INFLAMMATION AND PAIN | TRPA1, TRPV1, IL1B | FOLH1 4111/4885GABRP 960/4885GABRD 730/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.